Gastrointestinal smooth muscle contraction pathway

The gastrointestinal smooth muscle contraction pathway comprises a network of molecular signals that regulate the contractile state of smooth muscle in the GI tract. Canonical signaling begins with stimulation of muscarinic M3 (Gq/11) and M2 (Gi/o) receptors by acetylcholine released from enteric neurons, triggering downstream events such as activation of phospholipase C, generation of second messengers (IP3, diacylglycerol), release of calcium from the sarcoplasmic reticulum, and opening of voltage-dependent calcium channels and non-selective cation channels[1][3][6]. Interstitial cells of Cajal function as intrinsic pacemakers, generating rhythmic depolarizations ("slow waves") that coordinate contraction, while RhoA/Rho-kinase and PKC/CPI-17 pathways mediate calcium sensitization required for sustained contraction[2][4]. Additional modulation occurs via sympathetic (adrenergic) and parasympathetic (cholinergic) signals acting through enteric neurons[5]. Disruption of pathway components is linked to various motility disorders (e.g., achalasia, spasm, incontinence), and many pharmacological therapies target the pathway’s receptors, enzymes, or ion channels.

Other names

GI smooth muscle contractionGI motility pathwaysExcitation-contraction coupling in GI smooth muscle

Muscarinic receptor antagonism (prevents Ca2+ mobilization and contraction) - Inhibition of Ca2+ entry through ion channels (reduces intracellular Ca2+ required for contraction) - Inhibition of Rho kinase or PKC (prevents Ca2+ sensitization and sustained contraction) - β-adrenoceptor activation (promotes relaxation of smooth muscle)